Connect with us

Space & Satellites

Varda and United Therapeutics Partner for Orbital Drug Manufacturing

Varda Space Industries and United Therapeutics collaborate to develop microgravity-enabled treatments for rare pulmonary diseases using orbital pharmaceutical manufacturing.

Published

on

This article is based on an official press release from Varda Space Industries and United Therapeutics.

On May 13, 2026, Varda Space Industries and United Therapeutics Corporation announced a landmark collaboration to manufacture pharmaceuticals in low Earth orbit (LEO). The partnership focuses on developing microgravity-enabled treatments for rare pulmonary diseases, marking a significant milestone in the intersection of commercial spaceflight and biotechnology.

According to the official press release, this initiative represents the first-ever commercial research collaboration focused on space-based drug formulation aimed at producing tangible therapies for patients on Earth. By utilizing Varda’s automated reentry capsules, the companies aim to process small-molecule medicines in space and return them to Earth for clinical evaluation and eventual patient use.

This collaboration signals a major shift from traditional, government-funded research conducted on the International Space Station (ISS) to a dedicated commercial supply chain model. By leveraging the unique physics of zero gravity, the partnership strives to revolutionize how life-saving therapies are formulated and delivered.

The Science of Microgravity Manufacturing

The core advantage of orbital pharmaceutical manufacturing lies in the absence of Earth’s gravitational pull. On Earth, gravity induces sedimentation and convection currents that can disrupt how molecules assemble during the manufacturing process. In the weightless environment of space, these disruptive forces vanish.

According to the provided research report, this microgravity environment allows molecules to assemble more slowly and uniformly. The result is the creation of highly ordered crystal structures, known as polymorphs, that are either significantly purer or entirely impossible to synthesize in a terrestrial laboratory.

Targeted Pharmaceutical Benefits

By exploiting microgravity’s influence on molecular structure and crystallization, Varda and United Therapeutics hope to achieve several critical breakthroughs in drug formulation. The targeted benefits of this orbital processing include:

  • Improved Bioavailability: Allowing medications to dissolve and be absorbed more consistently by the human body.
  • Enhanced Stability: Extending the shelf life of medications and potentially reducing the need for expensive, complex cold-chain storage.
  • Advanced Delivery Methods: Enabling the creation of new inhaled or controlled-release therapies.
  • Targeted Efficiency: Formulating drugs that deliver active ingredients more efficiently to the intended site of action.

Commercializing Orbital Infrastructure

Varda Space Industries, an El Segundo, California-based startup founded in 2021 and backed by Founders Fund, is pioneering the infrastructure required for this endeavor. Unlike traditional microgravity research on the ISS, which is frequently bottlenecked by crew schedules, contamination risks, and long wait times for return flights, Varda utilizes automated, free-flying “W-series” reentry capsules.

These capsules are designed to launch as secondary payloads, often aboard SpaceX missions. Once in orbit, they autonomously process materials before returning the finished products to Earth, landing at designated recovery sites such as the Australian desert.

Industry Perspectives

Leadership from both companies emphasized the transformative potential of moving pharmaceutical development into orbit. In the official announcement, Varda Space Industries CEO Will Bruey highlighted the unique advantages of their platform:

“Microgravity gives us a fundamentally different environment to manufacture pharmaceuticals that are otherwise impossible on Earth. Our collaboration with United Therapeutics strives to pioneer a new era in clinical development by completing the bridge from microgravity science to patient benefit on Earth.”

Martine Rothblatt, Ph.D., Chairperson and CEO of United Therapeutics, noted in the release that the collaboration will allow the biotechnology firm to explore how space-based manufacturing could contribute to significant improvements for rare pulmonary disease treatments.

Michael Reilly, Chief Strategy Officer of Varda Space Industries, underscored the commercial novelty of the venture, pointing out the historical limitations of space research:

“We’ve been learning from space for years, but I can’t name anything manufactured in space, brought down to Earth, and sold. So that is a first, or it will be a first.”

Financial Context and Next Steps

United Therapeutics Corporation (Nasdaq: UTHR) is a biotechnology giant with a market capitalization of $24.69 billion, specializing in innovative therapies for life-threatening conditions like pulmonary arterial hypertension. Following the announcement of the collaboration, industry reports noted that United Therapeutics’ stock was trading near its 52-week high of $609.35, reflecting strong investor confidence in the company’s innovative pipeline.

While the specific compounds and exact financial terms of the deal remain undisclosed, the agreement stipulates that United Therapeutics is compensating Varda to help identify new crystal forms of its existing drugs.

The timeline for this orbital manufacturing initiative is advancing rapidly. According to the research report, a launch carrying United Therapeutics’ drug samples aboard a Varda capsule could occur as early as early 2027. Once the capsules return to Earth, scientists at United Therapeutics will rigorously test the newly formed polymorphs to evaluate their enhanced properties.

AirPro News analysis

We observe that this partnership answers a long-standing question in the aerospace sector: whether orbital drug manufacturing can successfully transition from a scientific curiosity to a viable, scalable business model. For over two decades, microgravity research has been largely confined to the ISS, yielding promising scientific results that rarely translated into commercial manufacturing pipelines due to logistical and financial constraints.

As launch costs continue to decrease and automated satellite technology matures, space-based manufacturing is rapidly emerging as a practical tool for terrestrial industries. If Varda and United Therapeutics are successful in returning commercially viable, enhanced pharmaceuticals from orbit, it could pave the way for a new era of space-enabled medicine, fundamentally altering the economic landscape of both the commercial space sector and the global biotechnology industry.

Frequently Asked Questions (FAQ)

What is the goal of the Varda and United Therapeutics collaboration?
The partnership aims to develop improved formulations of treatments for rare pulmonary diseases by manufacturing small-molecule medicines in the microgravity environment of low Earth orbit.

How does microgravity improve drug manufacturing?
In space, the absence of gravity eliminates sedimentation and convection currents. This allows molecules to assemble more slowly and uniformly, creating highly ordered crystal structures (polymorphs) that can improve a drug’s bioavailability, stability, and delivery methods.

When will the first manufacturing mission launch?
A launch carrying United Therapeutics’ drug samples aboard a Varda reentry capsule is projected to happen as early as early 2027.

How do the drugs return to Earth?
Varda utilizes automated “W-series” reentry capsules that process the materials in orbit and then reenter the Earth’s atmosphere, landing at designated recovery sites such as the Australian desert.

Sources

Photo Credit: Varda Space Industries

Continue Reading
Click to comment

Leave a Reply

Space & Satellites

NASA Awards $10.5M for Aerospace Skilled Workforce Hubs

NASA funds seven regional hubs to train welders, electricians, and machinists for lunar and Mars exploration programs.

Published

on

The National Aeronautics and Space Administration (NASA) has awarded approximately $10.5 million to establish seven regional workforce hubs across the United States, targeting a critical shortage of skilled technical labor required for the agency’s lunar and Martian exploration goals.

Announced on August 19, 2026, the three-year initiative focuses on developing career pathways for high-demand roles such as welders, electricians, and machinists. According to the agency’s press release, these positions require advanced science, technology, engineering, and mathematics (STEM) knowledge but do not necessitate a bachelor’s degree.

Addressing the technical talent pipeline

The funding is administered through the NASA Office of STEM Engagement and its Next Gen STEM Project. The initiative, officially named the NASA Aerospace Skilled Technical Workforce Hubs, is designed to align state-level educational training directly with the needs of the aerospace industry.

“The need for technical talent is already urgent and will only continue to grow as we return humanity to the Moon and set our sights on Mars and beyond,” said Elaine Ho, Associate Administrator for the Office of STEM Engagement at NASA Headquarters.

Ho noted that the agency is positioned to act as a catalyst to accelerate workforce development and foster the next generation of technicians. The seven institutions selected to host the new workforce hubs span the country:

  • Antelope Valley Community College District (California)
  • State Board for Community Colleges and Occupation Education, Arapahoe Community College (Colorado)
  • Space Florida (Florida)
  • Georgia Tech Research Corporation (Georgia)
  • Minnesota State Colleges and Universities (Minnesota)
  • Texas Space Commission (Texas)
  • Southern Utah University (Utah)

State-level implementation and funding targets

Following the federal announcement, several of the selected institutions detailed their specific funding allocations and program goals. In Colorado, Arapahoe Community College and its Colorado Space Institute will receive $1.3 million over the three-year period to act as a statewide convener for aerospace workforce development.

Colorado Governor Jared Polis highlighted the state’s position in the sector, stating that the designation will help residents build the skills needed to launch careers in the growing industry.

Minnesota State Colleges and Universities announced a $1.5 million share of the federal funding. The Minnesota system aims to enroll between 1,800 and 2,400 students in aerospace-related career paths through the initiative. Additionally, the state plans to create up to 200 new registered apprenticeships and internships to bridge the gap between classroom instruction and active manufacturing floors.

Other states are launching branded initiatives to organize their efforts. Space Florida will utilize its funding to advance “Project ORBIT,” a program designed to unify the state’s education, training, and industry systems to support NASA mission requirements. Similarly, Southern Utah University will lead the Utah NASA Aerospace Skilled Technical Workforce Hub to build a coordination system that aligns statewide training directly with local employer needs.

AirPro News analysis

We view this targeted $10.5 million investment as a necessary recalibration of aerospace workforce priorities. While industry discussions frequently center on shortages of pilots and degreed aerospace engineers, the most immediate bottleneck for both commercial aviation and space exploration lies on the manufacturing floor. The production of launch vehicles, spacecraft, and supporting infrastructure relies heavily on specialized welders, electricians, and composite technicians.

By directing federal funds specifically toward community colleges and state technical systems, NASA is acknowledging that the traditional four-year university track is not the only viable pathway into the space economy. Establishing these hubs at the state level also allows training programs to adapt to the specific manufacturing footprints of local aerospace employers, potentially reducing the time it takes to transition students from apprenticeships to full-time technical roles.

Sources: NASA

Photo Credit: NASA

Continue Reading

Space & Satellites

Firefly Aerospace and Zeno Power Target 2028 Lunar Night Mission

Firefly Aerospace and Zeno Power will integrate a radioisotope heater unit on a 2028 Blue Ghost lunar lander mission.

Published

on

Startups: FLY) and Zeno Power Systems have finalized a commercial payload agreement to integrate a specialized radioisotope heater unit onto a future Blue Ghost lunar lander, a system designed to keep spacecraft operational through the deep freeze of the lunar night. Announced in a press release on August 19, 2026, the mission is targeted for launch no earlier than 2028 and will head to the near side of the Moon.

The integration of Zeno Power’s “Survive-the-Night Package” aims to address a critical capability gap identified by the National Aeronautics and Space Administration (NASA) for sustained lunar exploration and the development of future Moon Base infrastructure.

Overcoming the lunar thermal environment

The lunar day and night cycle presents one of the most severe environmental challenges for spacecraft design. A single lunar night lasts approximately 14 Earth days, during which surface temperatures plummet. Data collected during Firefly Aerospace’s Blue Ghost Mission 1 in 2025 recorded temperatures exceeding 230 degrees Fahrenheit during the lunar day and dropping below -275 degrees Fahrenheit after sunset.

Previous commercial lunar landers have successfully operated using solar power during the lunar day but routinely ceased operations once the sun set and thermal limits were exceeded. The upcoming 2028 mission will operate under NASA’s Commercial Lunar Payload Services (CLPS) initiative. Upon landing, the Blue Ghost spacecraft will utilize solar power to run multiple NASA CLPS payloads for the duration of the lunar day. Once darkness falls, Zeno Power’s payload will take over operations, transmitting data back to Earth throughout the lunar night.

“Firefly is proud to collaborate with innovative companies like Zeno to solve one of the most complex challenges of lunar exploration—surviving the lunar night. Our first Blue Ghost mission gave us firsthand insight into the Moon’s extreme thermal environment, where we measured temperatures ranging from more than 230°F during the lunar day to below -275°F at night. Now we’re looking forward to advancing technologies that can extend missions beyond sunset and support long-duration surface operations required for NASA’s Moon Base initiative and the growing lunar economy.” — Ray Allensworth, Vice President of Spacecraft at Firefly Aerospace

Radioisotope technology and payload specifications

The core of the Survive-the-Night Package is a Radioisotope Heater Unit (RHU) developed by Zeno Power. The system utilizes americium-241, a radioactive isotope that generates passive thermal energy through natural decay. This process provides continuous heat without relying on solar arrays or battery reserves.

According to the press release, the RHU will generate 5 Watts of thermal energy. The complete payload package includes a dedicated platform equipped with structural, communications, electrical power, command and data handling, and thermal management subsystems.

Tyler Bernstein, CEO and Co-Founder of Zeno Power, emphasized the necessity of the technology for future missions.

“Hardware capable of surviving the extreme cold of the lunar night will be essential to enabling sustained operations on the Moon. NASA’s Moon Base Program has identified the need for technologies such as radioisotope power systems to support future lunar exploration, and Zeno is proud to answer that call to demonstrate this capability aboard Firefly’s Blue Ghost mission. As demand for long-duration lunar infrastructure grows, we are building the production capacity to support future commercial and government missions.”

AirPro News analysis

The inability to survive the 14-day lunar night has been a hard ceiling for commercial lunar operations. By integrating americium-241 radioisotope technology, Firefly Aerospace and Zeno Power are targeting a bottleneck that must be resolved before NASA can establish permanent or semi-permanent lunar infrastructure. We view this 2028 demonstration as a critical proving ground. If the Survive-the-Night Package successfully maintains command, data handling, and communications through the -275-degree Fahrenheit freeze, it will validate a scalable thermal management model for future commercial landers, rovers, and stationary habitats. The shift from solar-dependent, single-lunar-day missions to continuous operations is a prerequisite for a viable commercial lunar economy.

Sources: Firefly Aerospace

Photo Credit: Firefly Aerospace

Continue Reading

Space & Satellites

NASA Cancels Swift Observatory Boost After LINK Spacecraft Issues

NASA and Katalyst Space cancel the Swift Boost capture phase after attitude control issues. Swift Observatory faces uncontrolled reentry.

Published

on

NASA and Katalyst Space Technologies announced on August 19, 2026, that the commercial LINK spacecraft will no longer attempt to capture and boost the Neil Gehrels Swift Observatory in low Earth orbit. The mission will instead pivot to gathering data through rendezvous and proximity operations following persistent attitude control issues with the LINK vehicle.

In a press release issued by NASA, the agency confirmed the cancellation of the capture phase of the $30 million Swift Boost mission. The unprecedented commercial effort was designed to extend the life of the 20-year-old observatory, which has experienced accelerated orbital decay due to increased solar activity. With the boost attempt aborted, the Swift Observatory is expected to undergo an uncontrolled reentry into Earth’s atmosphere later this year.

Mission timeline and technical challenges

Katalyst Space Technologies designed, built, and launched the LINK spacecraft in less than a year. The vehicle deployed into orbit on July 3, 2026, aboard a Northrop Grumman Pegasus XL rocket, which was air-launched from an L-1011 Stargazer aircraft over the Kwajalein Atoll in the Republic of the Marshall Islands.

Following the launch, the LINK spacecraft encountered attitude control anomalies. On August 11, 2026, Katalyst Space successfully uploaded a flight Software update that temporarily reestablished control. Ongoing issues ultimately precluded the complex robotic capture of the government spacecraft, which was not originally designed for on-orbit servicing. Prior to the pivot, NASA had maintained the Swift Observatory at a minimum altitude of 185 miles (300 kilometers) to optimize the chances of a successful boost.

Strategic pivot and industry response

Rather than attempting the physical capture, the LINK spacecraft will now conduct rendezvous and proximity operations near the Swift Observatory. This revised flight profile aims to collect data that will inform future satellite servicing missions.

NASA Administrator Jared Isaacman defended the rapid-acquisition approach and the decision to attempt the high-risk mission.

“NASA should be willing to move quickly and take smart risks when the potential return is worth it, and that is exactly what we did with this mission. This is not the outcome we were working toward, but it does not change why this mission was worth attempting.”

Isaacman added that the agency intends to apply the lessons learned from the rendezvous attempt to subsequent missions. Katalyst Space Technologies CEO Ghonhee Lee emphasized the value of the milestones achieved during the accelerated development cycle. Lee stated that the company’s focus is now on building a repeatable playbook for future proximity operations and satellite servicing based on the experimental spacecraft’s performance.

AirPro News analysis

The pivot of the Swift Boost mission highlights the inherent difficulties of on-orbit servicing, particularly when interacting with legacy assets lacking dedicated capture interfaces. While the failure to boost the Swift Observatory represents a loss for the immediate scientific community relying on its data, the mission’s rapid procurement and deployment model remains a notable shift in government contracting. We view the $30 million fixed-price approach as a template NASA is likely to reuse. The willingness to accept higher mission risk for lower cost and faster deployment indicates a maturing relationship between federal space agencies and agile commercial spaceflight Startups, even when primary mission objectives are not fully realized.

Sources: NASA

Photo Credit: NASA

Continue Reading
Every coffee directly supports the work behind the headlines.

Support AirPro News!

Advertisement

Follow Us

newsletter

Latest

Categories

Tags

Every coffee directly supports the work behind the headlines.

Support AirPro News!

Popular News